CRDC UK Network holds first national conference to strengthen collaboration across commercial clinical research
12 November 2026
On 6 November 2026, the CRDC UK Network welcomed over 140 delegates to its first national conference at the National Conference Centre in Birmingham, bringing together colleagues from Commercial Research Delivery Centres (CRDCs) and CRDCs in Primary Care (CRDC-PCs), alongside industry colleagues, regulatory bodies and the wider research infrastructure.
Under the theme Delivering Research Impact Through Collaboration Across the UK, the conference provided an opportunity to share learning, discuss common challenges and explore practical solutions to strengthen commercial clinical research delivery.
The day opened with remarks from Richard Mitchell, Chief Executive of University Hospitals of Leicester NHS Trust, which hosts the CRDC UK Network, Professor Mike Lewis, NIHR Scientific Director of Innovation, and Richard Torbett MBE, Chief Executive of the ABPI. Delegates also heard updates on recent achievements and progress across the CRDC UK Network and UKCRF Network from Professor Lorraine Harper, Co-Director and Clinical Lead of the CRDC UK Network, and Paul Brown, Director of the UKCRF Network.
Sessions throughout the day focused on some of the key priorities and opportunities facing commercial clinical research delivery. Professor Mike Lewis and Dr Maria Koufali, NIHR Life Sciences Industry Director, outlined recent developments and key areas of focus for the NIHR Industry Hub, while Dr Christiana Dinah, Director of the NIHR CRDC: North West London, and Professor Seshadri Vasan, Director of the NHS Grampian CRDC, shared how their BRIDGE the Gap strategy is helping to improve research inclusion and broaden access to commercial clinical research opportunities.
Panel discussions brought together representatives from CRDCs, industry and regulators to share perspectives and practical experience. Topics included multi-location study delivery and investigational medicinal product (IMP) movement, opportunities to expand commercial research through primary care, and the role of UK clinical expertise in attracting and delivering commercial studies. Contributors included colleagues from Novartis, Novo Nordisk, the Health Research Authority and CRDCs from across England, Scotland, Wales and Northern Ireland.
A clear message emerged throughout the day: collaboration across organisations, sectors and nations is essential to improving access to research, accelerating study delivery and ensuring the UK remains an attractive destination for commercial clinical research. The conference highlighted the value of bringing together those delivering,
supporting and sponsoring research to share challenges, identify solutions and strengthen partnerships across the UK.
Professor Lorraine Harper, Co-Director for the CRDC UK Network, said: "Bringing together colleagues from across the four nations, alongside industry and regulatory partners, created a valuable opportunity to share learning and explore solutions to some of the key challenges facing commercial research delivery. As the Network's first national conference, the event demonstrated the strength of collaboration across the UK and the important role that partnership will continue to play in improving research opportunities for patients and supporting the UK's global competitiveness in commercial clinical research."
Get in touch to find out more about working with the CRDC UK Network to deliver commercial research in the UK.
Further news